We are proud to share with you our inaugural issue of The Signature, the WVU Cancer Institute Annual Report.
The stories of hope, innovation and partnership contained within this publication help illustrate our commitment to provide optimal care and services to patients and their families throughout West Virginia and beyond.
You’ll read how we are increasing access to cancer care by broadening our network of services; engaging West Virginia communities in initiatives and programs that promote early screening to detect cancer early when it’s most treatable; individualizing treatment plans for each patient through multidisciplinary, disease-focused teams of cancer specialists; and advancing cancer care through cutting-edge research and technologies.
We hope you are encouraged by these efforts to build a healthier state.
The WVU Cancer Institute is the first institution in the United States to offer intraoperative radiation therapy (IORT) to treat glioblastoma.
Several events at this year’s West Virginia Writers’ Workshop, July 20-23 at WVU, are focused on the role of writing and storytelling in health. Presenters include narrative medicine faculty from several campuses across the U.S., along with the leaders of an expressive writing program for patients at the WVU Cancer Institute. Health sciences faculty, staff and students are invited to participate in some or all of the Workshop.
WVU cancer researcher participates in study that shows promising treatments for certain patients with advanced colorectal cancer
A group of cancer researchers, including Richard Goldberg, M.D., director of the WVU Cancer Institute, released a study today in the Journal of the American Medical Association comparing the results of combinations of chemotherapy delivered with targeted therapy drugs in the treatment of people with advanced colorectal cancer who had not received prior drug treatment for their advanced disease.